Global Spinal Muscular Atrophy Genetic Detection Market Insights, Forecast to 2029
This report presents an overview of global market for Spinal Muscular Atrophy Genetic Detection market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Spinal Muscular Atrophy Genetic Detection, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Spinal Muscular Atrophy Genetic Detection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Spinal Muscular Atrophy Genetic Detection revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Spinal Muscular Atrophy Genetic Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Spinal Muscular Atrophy Genetic Detection revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including United Gene Group, Berrygenomics, Sanvalley, Microread and Genecore, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Spinal Muscular Atrophy Genetic Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Spinal Muscular Atrophy Genetic Detection companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Spinal Muscular Atrophy Genetic Detection revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Spinal Muscular Atrophy Genetic Detection, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Spinal Muscular Atrophy Genetic Detection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Spinal Muscular Atrophy Genetic Detection revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Spinal Muscular Atrophy Genetic Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Spinal Muscular Atrophy Genetic Detection revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including United Gene Group, Berrygenomics, Sanvalley, Microread and Genecore, etc.
By Company
- United Gene Group
- Berrygenomics
- Sanvalley
- Microread
- Genecore
- Genetic Screening
- Reproductive Genetic Testing
- Diagnostic Test
- Gene carrier Test
- Testing Before Symptoms Appear
- Hospital
- Clinic
- Diagnostic Center
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Spinal Muscular Atrophy Genetic Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Spinal Muscular Atrophy Genetic Detection companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Spinal Muscular Atrophy Genetic Detection revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Genetic Screening
1.2.3 Reproductive Genetic Testing
1.2.4 Diagnostic Test
1.2.5 Gene carrier Test
1.2.6 Testing Before Symptoms Appear
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Spinal Muscular Atrophy Genetic Detection Market Perspective (2018-2029)
2.2 Global Spinal Muscular Atrophy Genetic Detection Growth Trends by Region
2.2.1 Spinal Muscular Atrophy Genetic Detection Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Spinal Muscular Atrophy Genetic Detection Historic Market Size by Region (2018-2023)
2.2.3 Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Region (2024-2029)
2.3 Spinal Muscular Atrophy Genetic Detection Market Dynamics
2.3.1 Spinal Muscular Atrophy Genetic Detection Industry Trends
2.3.2 Spinal Muscular Atrophy Genetic Detection Market Drivers
2.3.3 Spinal Muscular Atrophy Genetic Detection Market Challenges
2.3.4 Spinal Muscular Atrophy Genetic Detection Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Spinal Muscular Atrophy Genetic Detection by Players
3.1.1 Global Spinal Muscular Atrophy Genetic Detection Revenue by Players (2018-2023)
3.1.2 Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Players (2018-2023)
3.2 Global Spinal Muscular Atrophy Genetic Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Spinal Muscular Atrophy Genetic Detection, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Spinal Muscular Atrophy Genetic Detection Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy Genetic Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Genetic Detection Revenue in 2022
3.5 Global Key Players of Spinal Muscular Atrophy Genetic Detection Head office and Area Served
3.6 Global Key Players of Spinal Muscular Atrophy Genetic Detection, Product and Application
3.7 Global Key Players of Spinal Muscular Atrophy Genetic Detection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 SPINAL MUSCULAR ATROPHY GENETIC DETECTION BREAKDOWN DATA BY TYPE
4.1 Global Spinal Muscular Atrophy Genetic Detection Historic Market Size by Type (2018-2023)
4.2 Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Type (2024-2029)
5 SPINAL MUSCULAR ATROPHY GENETIC DETECTION BREAKDOWN DATA BY APPLICATION
5.1 Global Spinal Muscular Atrophy Genetic Detection Historic Market Size by Application (2018-2023)
5.2 Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Spinal Muscular Atrophy Genetic Detection Market Size (2018-2029)
6.2 North America Spinal Muscular Atrophy Genetic Detection Market Size by Type
6.2.1 North America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023)
6.2.2 North America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029)
6.2.3 North America Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
6.3 North America Spinal Muscular Atrophy Genetic Detection Market Size by Application
6.3.1 North America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023)
6.3.2 North America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029)
6.3.3 North America Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
6.4 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country
6.4.1 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2018-2023)
6.4.3 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size (2018-2029)
7.2 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type
7.2.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023)
7.2.2 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029)
7.2.3 Europe Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
7.3 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application
7.3.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023)
7.3.2 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029)
7.3.3 Europe Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
7.4 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country
7.4.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2018-2023)
7.4.3 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Spinal Muscular Atrophy Genetic Detection Market Size (2018-2029)
8.2 China Spinal Muscular Atrophy Genetic Detection Market Size by Type
8.2.1 China Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023)
8.2.2 China Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029)
8.2.3 China Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
8.3 China Spinal Muscular Atrophy Genetic Detection Market Size by Application
8.3.1 China Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023)
8.3.2 China Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029)
8.3.3 China Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Spinal Muscular Atrophy Genetic Detection Market Size (2018-2029)
9.2 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Type
9.2.1 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023)
9.2.2 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029)
9.2.3 Asia Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
9.3 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Application
9.3.1 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023)
9.3.2 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029)
9.3.3 Asia Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
9.4 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Region
9.4.1 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Region (2018-2023)
9.4.3 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type
10.2.1 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application
10.3.1 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country
10.4.1 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 United Gene Group
11.1.1 United Gene Group Company Details
11.1.2 United Gene Group Business Overview
11.1.3 United Gene Group Spinal Muscular Atrophy Genetic Detection Introduction
11.1.4 United Gene Group Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
11.1.5 United Gene Group Recent Developments
11.2 Berrygenomics
11.2.1 Berrygenomics Company Details
11.2.2 Berrygenomics Business Overview
11.2.3 Berrygenomics Spinal Muscular Atrophy Genetic Detection Introduction
11.2.4 Berrygenomics Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
11.2.5 Berrygenomics Recent Developments
11.3 Sanvalley
11.3.1 Sanvalley Company Details
11.3.2 Sanvalley Business Overview
11.3.3 Sanvalley Spinal Muscular Atrophy Genetic Detection Introduction
11.3.4 Sanvalley Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
11.3.5 Sanvalley Recent Developments
11.4 Microread
11.4.1 Microread Company Details
11.4.2 Microread Business Overview
11.4.3 Microread Spinal Muscular Atrophy Genetic Detection Introduction
11.4.4 Microread Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
11.4.5 Microread Recent Developments
11.5 Genecore
11.5.1 Genecore Company Details
11.5.2 Genecore Business Overview
11.5.3 Genecore Spinal Muscular Atrophy Genetic Detection Introduction
11.5.4 Genecore Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
11.5.5 Genecore Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Genetic Screening
1.2.3 Reproductive Genetic Testing
1.2.4 Diagnostic Test
1.2.5 Gene carrier Test
1.2.6 Testing Before Symptoms Appear
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Spinal Muscular Atrophy Genetic Detection Market Perspective (2018-2029)
2.2 Global Spinal Muscular Atrophy Genetic Detection Growth Trends by Region
2.2.1 Spinal Muscular Atrophy Genetic Detection Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Spinal Muscular Atrophy Genetic Detection Historic Market Size by Region (2018-2023)
2.2.3 Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Region (2024-2029)
2.3 Spinal Muscular Atrophy Genetic Detection Market Dynamics
2.3.1 Spinal Muscular Atrophy Genetic Detection Industry Trends
2.3.2 Spinal Muscular Atrophy Genetic Detection Market Drivers
2.3.3 Spinal Muscular Atrophy Genetic Detection Market Challenges
2.3.4 Spinal Muscular Atrophy Genetic Detection Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Spinal Muscular Atrophy Genetic Detection by Players
3.1.1 Global Spinal Muscular Atrophy Genetic Detection Revenue by Players (2018-2023)
3.1.2 Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Players (2018-2023)
3.2 Global Spinal Muscular Atrophy Genetic Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Spinal Muscular Atrophy Genetic Detection, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Spinal Muscular Atrophy Genetic Detection Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy Genetic Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Genetic Detection Revenue in 2022
3.5 Global Key Players of Spinal Muscular Atrophy Genetic Detection Head office and Area Served
3.6 Global Key Players of Spinal Muscular Atrophy Genetic Detection, Product and Application
3.7 Global Key Players of Spinal Muscular Atrophy Genetic Detection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 SPINAL MUSCULAR ATROPHY GENETIC DETECTION BREAKDOWN DATA BY TYPE
4.1 Global Spinal Muscular Atrophy Genetic Detection Historic Market Size by Type (2018-2023)
4.2 Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Type (2024-2029)
5 SPINAL MUSCULAR ATROPHY GENETIC DETECTION BREAKDOWN DATA BY APPLICATION
5.1 Global Spinal Muscular Atrophy Genetic Detection Historic Market Size by Application (2018-2023)
5.2 Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Spinal Muscular Atrophy Genetic Detection Market Size (2018-2029)
6.2 North America Spinal Muscular Atrophy Genetic Detection Market Size by Type
6.2.1 North America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023)
6.2.2 North America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029)
6.2.3 North America Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
6.3 North America Spinal Muscular Atrophy Genetic Detection Market Size by Application
6.3.1 North America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023)
6.3.2 North America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029)
6.3.3 North America Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
6.4 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country
6.4.1 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2018-2023)
6.4.3 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size (2018-2029)
7.2 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type
7.2.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023)
7.2.2 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029)
7.2.3 Europe Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
7.3 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application
7.3.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023)
7.3.2 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029)
7.3.3 Europe Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
7.4 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country
7.4.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2018-2023)
7.4.3 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Spinal Muscular Atrophy Genetic Detection Market Size (2018-2029)
8.2 China Spinal Muscular Atrophy Genetic Detection Market Size by Type
8.2.1 China Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023)
8.2.2 China Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029)
8.2.3 China Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
8.3 China Spinal Muscular Atrophy Genetic Detection Market Size by Application
8.3.1 China Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023)
8.3.2 China Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029)
8.3.3 China Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Spinal Muscular Atrophy Genetic Detection Market Size (2018-2029)
9.2 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Type
9.2.1 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023)
9.2.2 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029)
9.2.3 Asia Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
9.3 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Application
9.3.1 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023)
9.3.2 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029)
9.3.3 Asia Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
9.4 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Region
9.4.1 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Region (2018-2023)
9.4.3 Asia Spinal Muscular Atrophy Genetic Detection Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type
10.2.1 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application
10.3.1 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country
10.4.1 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 United Gene Group
11.1.1 United Gene Group Company Details
11.1.2 United Gene Group Business Overview
11.1.3 United Gene Group Spinal Muscular Atrophy Genetic Detection Introduction
11.1.4 United Gene Group Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
11.1.5 United Gene Group Recent Developments
11.2 Berrygenomics
11.2.1 Berrygenomics Company Details
11.2.2 Berrygenomics Business Overview
11.2.3 Berrygenomics Spinal Muscular Atrophy Genetic Detection Introduction
11.2.4 Berrygenomics Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
11.2.5 Berrygenomics Recent Developments
11.3 Sanvalley
11.3.1 Sanvalley Company Details
11.3.2 Sanvalley Business Overview
11.3.3 Sanvalley Spinal Muscular Atrophy Genetic Detection Introduction
11.3.4 Sanvalley Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
11.3.5 Sanvalley Recent Developments
11.4 Microread
11.4.1 Microread Company Details
11.4.2 Microread Business Overview
11.4.3 Microread Spinal Muscular Atrophy Genetic Detection Introduction
11.4.4 Microread Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
11.4.5 Microread Recent Developments
11.5 Genecore
11.5.1 Genecore Company Details
11.5.2 Genecore Business Overview
11.5.3 Genecore Spinal Muscular Atrophy Genetic Detection Introduction
11.5.4 Genecore Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
11.5.5 Genecore Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Reproductive Genetic Testing
Table 4. Key Players of Diagnostic Test
Table 5. Key Players of Gene carrier Test
Table 6. Key Players of Testing Before Symptoms Appear
Table 7. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Spinal Muscular Atrophy Genetic Detection Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Spinal Muscular Atrophy Genetic Detection Market Share by Region (2018-2023)
Table 11. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Spinal Muscular Atrophy Genetic Detection Market Share by Region (2024-2029)
Table 13. Spinal Muscular Atrophy Genetic Detection Market Trends
Table 14. Spinal Muscular Atrophy Genetic Detection Market Drivers
Table 15. Spinal Muscular Atrophy Genetic Detection Market Challenges
Table 16. Spinal Muscular Atrophy Genetic Detection Market Restraints
Table 17. Global Spinal Muscular Atrophy Genetic Detection Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Spinal Muscular Atrophy Genetic Detection Revenue Share by Players (2018-2023)
Table 19. Global Top Spinal Muscular Atrophy Genetic Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Genetic Detection as of 2022)
Table 20. Global Spinal Muscular Atrophy Genetic Detection Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Spinal Muscular Atrophy Genetic Detection Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Spinal Muscular Atrophy Genetic Detection, Headquarters and Area Served
Table 23. Global Key Players of Spinal Muscular Atrophy Genetic Detection, Product and Application
Table 24. Global Key Players of Spinal Muscular Atrophy Genetic Detection, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Type (2018-2023)
Table 28. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Type (2024-2029)
Table 30. Global Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Spinal Muscular Atrophy Genetic Detection Revenue Share by Application (2018-2023)
Table 32. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Spinal Muscular Atrophy Genetic Detection Revenue Share by Application (2024-2029)
Table 34. North America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Spinal Muscular Atrophy Genetic Detection Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Spinal Muscular Atrophy Genetic Detection Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Spinal Muscular Atrophy Genetic Detection Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Spinal Muscular Atrophy Genetic Detection Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Spinal Muscular Atrophy Genetic Detection Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2024-2029) & (US$ Million)
Table 66. United Gene Group Company Details
Table 67. United Gene Group Business Overview
Table 68. United Gene Group Spinal Muscular Atrophy Genetic Detection Product
Table 69. United Gene Group Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023) & (US$ Million)
Table 70. United Gene Group Recent Developments
Table 71. Berrygenomics Company Details
Table 72. Berrygenomics Business Overview
Table 73. Berrygenomics Spinal Muscular Atrophy Genetic Detection Product
Table 74. Berrygenomics Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023) & (US$ Million)
Table 75. Berrygenomics Recent Developments
Table 76. Sanvalley Company Details
Table 77. Sanvalley Business Overview
Table 78. Sanvalley Spinal Muscular Atrophy Genetic Detection Product
Table 79. Sanvalley Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023) & (US$ Million)
Table 80. Sanvalley Recent Developments
Table 81. Microread Company Details
Table 82. Microread Business Overview
Table 83. Microread Spinal Muscular Atrophy Genetic Detection Product
Table 84. Microread Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023) & (US$ Million)
Table 85. Microread Recent Developments
Table 86. Genecore Company Details
Table 87. Genecore Business Overview
Table 88. Genecore Spinal Muscular Atrophy Genetic Detection Product
Table 89. Genecore Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023) & (US$ Million)
Table 90. Genecore Recent Developments
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 1. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Reproductive Genetic Testing
Table 4. Key Players of Diagnostic Test
Table 5. Key Players of Gene carrier Test
Table 6. Key Players of Testing Before Symptoms Appear
Table 7. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Spinal Muscular Atrophy Genetic Detection Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Spinal Muscular Atrophy Genetic Detection Market Share by Region (2018-2023)
Table 11. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Spinal Muscular Atrophy Genetic Detection Market Share by Region (2024-2029)
Table 13. Spinal Muscular Atrophy Genetic Detection Market Trends
Table 14. Spinal Muscular Atrophy Genetic Detection Market Drivers
Table 15. Spinal Muscular Atrophy Genetic Detection Market Challenges
Table 16. Spinal Muscular Atrophy Genetic Detection Market Restraints
Table 17. Global Spinal Muscular Atrophy Genetic Detection Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Spinal Muscular Atrophy Genetic Detection Revenue Share by Players (2018-2023)
Table 19. Global Top Spinal Muscular Atrophy Genetic Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Genetic Detection as of 2022)
Table 20. Global Spinal Muscular Atrophy Genetic Detection Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Spinal Muscular Atrophy Genetic Detection Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Spinal Muscular Atrophy Genetic Detection, Headquarters and Area Served
Table 23. Global Key Players of Spinal Muscular Atrophy Genetic Detection, Product and Application
Table 24. Global Key Players of Spinal Muscular Atrophy Genetic Detection, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Type (2018-2023)
Table 28. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Type (2024-2029)
Table 30. Global Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Spinal Muscular Atrophy Genetic Detection Revenue Share by Application (2018-2023)
Table 32. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Spinal Muscular Atrophy Genetic Detection Revenue Share by Application (2024-2029)
Table 34. North America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Spinal Muscular Atrophy Genetic Detection Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Spinal Muscular Atrophy Genetic Detection Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Spinal Muscular Atrophy Genetic Detection Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Spinal Muscular Atrophy Genetic Detection Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Spinal Muscular Atrophy Genetic Detection Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2024-2029) & (US$ Million)
Table 66. United Gene Group Company Details
Table 67. United Gene Group Business Overview
Table 68. United Gene Group Spinal Muscular Atrophy Genetic Detection Product
Table 69. United Gene Group Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023) & (US$ Million)
Table 70. United Gene Group Recent Developments
Table 71. Berrygenomics Company Details
Table 72. Berrygenomics Business Overview
Table 73. Berrygenomics Spinal Muscular Atrophy Genetic Detection Product
Table 74. Berrygenomics Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023) & (US$ Million)
Table 75. Berrygenomics Recent Developments
Table 76. Sanvalley Company Details
Table 77. Sanvalley Business Overview
Table 78. Sanvalley Spinal Muscular Atrophy Genetic Detection Product
Table 79. Sanvalley Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023) & (US$ Million)
Table 80. Sanvalley Recent Developments
Table 81. Microread Company Details
Table 82. Microread Business Overview
Table 83. Microread Spinal Muscular Atrophy Genetic Detection Product
Table 84. Microread Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023) & (US$ Million)
Table 85. Microread Recent Developments
Table 86. Genecore Company Details
Table 87. Genecore Business Overview
Table 88. Genecore Spinal Muscular Atrophy Genetic Detection Product
Table 89. Genecore Revenue in Spinal Muscular Atrophy Genetic Detection Business (2018-2023) & (US$ Million)
Table 90. Genecore Recent Developments
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Spinal Muscular Atrophy Genetic Detection Market Share by Type: 2022 VS 2029
Figure 3. Genetic Screening Features
Figure 4. Reproductive Genetic Testing Features
Figure 5. Diagnostic Test Features
Figure 6. Gene carrier Test Features
Figure 7. Testing Before Symptoms Appear Features
Figure 8. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Spinal Muscular Atrophy Genetic Detection Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Diagnostic Center Case Studies
Figure 13. Spinal Muscular Atrophy Genetic Detection Report Years Considered
Figure 14. Global Spinal Muscular Atrophy Genetic Detection Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Spinal Muscular Atrophy Genetic Detection Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Spinal Muscular Atrophy Genetic Detection Market Share by Region: 2022 VS 2029
Figure 17. Global Spinal Muscular Atrophy Genetic Detection Market Share by Players in 2022
Figure 18. Global Top Spinal Muscular Atrophy Genetic Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Genetic Detection as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Genetic Detection Revenue in 2022
Figure 20. North America Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
Figure 22. North America Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
Figure 23. North America Spinal Muscular Atrophy Genetic Detection Market Share by Country (2018-2029)
Figure 24. United States Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Spinal Muscular Atrophy Genetic Detection Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
Figure 28. Europe Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
Figure 29. Europe Spinal Muscular Atrophy Genetic Detection Market Share by Country (2018-2029)
Figure 30. Germany Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Spinal Muscular Atrophy Genetic Detection Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
Figure 38. China Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
Figure 39. Asia Spinal Muscular Atrophy Genetic Detection Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
Figure 41. Asia Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
Figure 42. Asia Spinal Muscular Atrophy Genetic Detection Market Share by Region (2018-2029)
Figure 43. Japan Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Country (2018-2029)
Figure 53. Brazil Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. United Gene Group Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
Figure 60. Berrygenomics Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
Figure 61. Sanvalley Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
Figure 62. Microread Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
Figure 63. Genecore Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Figure 1. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Spinal Muscular Atrophy Genetic Detection Market Share by Type: 2022 VS 2029
Figure 3. Genetic Screening Features
Figure 4. Reproductive Genetic Testing Features
Figure 5. Diagnostic Test Features
Figure 6. Gene carrier Test Features
Figure 7. Testing Before Symptoms Appear Features
Figure 8. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Spinal Muscular Atrophy Genetic Detection Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Diagnostic Center Case Studies
Figure 13. Spinal Muscular Atrophy Genetic Detection Report Years Considered
Figure 14. Global Spinal Muscular Atrophy Genetic Detection Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Spinal Muscular Atrophy Genetic Detection Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Spinal Muscular Atrophy Genetic Detection Market Share by Region: 2022 VS 2029
Figure 17. Global Spinal Muscular Atrophy Genetic Detection Market Share by Players in 2022
Figure 18. Global Top Spinal Muscular Atrophy Genetic Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Genetic Detection as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Genetic Detection Revenue in 2022
Figure 20. North America Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
Figure 22. North America Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
Figure 23. North America Spinal Muscular Atrophy Genetic Detection Market Share by Country (2018-2029)
Figure 24. United States Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Spinal Muscular Atrophy Genetic Detection Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
Figure 28. Europe Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
Figure 29. Europe Spinal Muscular Atrophy Genetic Detection Market Share by Country (2018-2029)
Figure 30. Germany Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Spinal Muscular Atrophy Genetic Detection Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
Figure 38. China Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
Figure 39. Asia Spinal Muscular Atrophy Genetic Detection Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
Figure 41. Asia Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
Figure 42. Asia Spinal Muscular Atrophy Genetic Detection Market Share by Region (2018-2029)
Figure 43. Japan Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Country (2018-2029)
Figure 53. Brazil Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. United Gene Group Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
Figure 60. Berrygenomics Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
Figure 61. Sanvalley Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
Figure 62. Microread Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
Figure 63. Genecore Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
